Literature DB >> 20096770

Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.

Krystle L Mohawk1, Angela R Melton-Celsa, Tonia Zangari, Erica E Carroll, Alison D O'Brien.   

Abstract

Escherichia coli O157:H7 is a food-borne pathogen that can cause hemorrhagic colitis and, occasionally, hemolytic uremic syndrome, a sequela of infection that can result in renal failure and death. Here we sought to model the pathogenesis of orally-administered E. coli O157:H7 in BALB/c mice with an intact intestinal flora. First, we defined the optimal dose that permitted sustained fecal shedding of E. coli O157:H7 over 7 days ( approximately 10(9) colony forming units). Next, we monitored the load of E. coli O157:H7 in intestinal sections over time and observed that the cecum was consistently the tissue with the highest E. coli O157:H7 recovery. We then followed the expression of two key E. coli O157:H7 virulence factors, the adhesin intimin and Shiga toxin type 2, and detected both proteins early in infection when bacterial burdens were highest. Additionally, we noted that during infection, animals lost weight and approximately 30% died. Moribund animals also exhibited elevated levels of blood urea nitrogen, and, on necropsy, showed evidence of renal tubular damage. We conclude that conventional mice inoculated orally with high doses of E. coli O157:H7 can be used to model both intestinal colonization and subsequent development of certain extraintestinal manifestations of E. coli O157:H7 disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096770      PMCID: PMC2834854          DOI: 10.1016/j.micpath.2010.01.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  47 in total

1.  Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d.

Authors:  J F Kokai-Kun; A R Melton-Celsa; A D O'Brien
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome.

Authors:  K Kaneko; N Kiyokawa; Y Ohtomo; R Nagaoka; Y Yamashiro; T Taguchi; T Mori; J Fujimoto; T Takeda
Journal:  Nephron       Date:  2001-02       Impact factor: 2.847

3.  Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome.

Authors:  U Chaisri; M Nagata; H Kurazono; H Horie; P Tongtawe; H Hayashi; T Watanabe; P Tapchaisri; M Chongsa-nguan; W Chaicumpa
Journal:  Microb Pathog       Date:  2001-08       Impact factor: 3.738

4.  Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

Authors:  X Zhang; A D McDaniel; L E Wolf; G T Keusch; M K Waldor; D W Acheson
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

5.  Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.

Authors:  L J Gansheroff; M R Wachtel; A D O'Brien
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli.

Authors:  I Matise; N A Cornick; S L Booher; J E Samuel; B T Bosworth; H W Moon
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

7.  A monkey model for enterohemorrhagic Escherichia coli infection.

Authors:  G Kang; A B Pulimood; R Koshi; A Hull; D Acheson; P Rajan; G T Keusch; V I Mathan; M M Mathan
Journal:  J Infect Dis       Date:  2001-06-18       Impact factor: 5.226

8.  Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli.

Authors:  S Yamagami; M Motoki; T Kimura; H Izumi; T Takeda; Y Katsuura; Y Matsumoto
Journal:  J Infect Dis       Date:  2001-08-09       Impact factor: 5.226

9.  Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease.

Authors:  N A Cornick; I Matise; J E Samuel; B T Bosworth; H W Moon
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

10.  Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces.

Authors:  Nicole A Judge; Hugh S Mason; Alison D O'Brien
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more
  31 in total

1.  Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24.

Authors:  Melissa M Kendall; Charley C Gruber; David A Rasko; David T Hughes; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

2.  Contribution of urease to colonization by Shiga toxin-producing Escherichia coli.

Authors:  Susan R Steyert; James B Kaper
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

3.  The Serotonin Neurotransmitter Modulates Virulence of Enteric Pathogens.

Authors:  Aman Kumar; Regan M Russell; Reed Pifer; Zelia Menezes-Garcia; Santiago Cuesta; Sanjeev Narayanan; John B MacMillan; Vanessa Sperandio
Journal:  Cell Host Microbe       Date:  2020-06-09       Impact factor: 21.023

4.  Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Cory M Robinson; Alison D O'Brien
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

5.  Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization.

Authors:  Alexander Corbishley; Nur Indah Ahmad; Kirsty Hughes; Michael R Hutchings; Sean P McAteer; Timothy K Connelley; Helen Brown; David L Gally; Tom N McNeilly
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

6.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

7.  Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis.

Authors:  Somshuvra Mukhopadhyay; Adam D Linstedt
Journal:  Science       Date:  2012-01-20       Impact factor: 47.728

8.  The Type Three Secretion System 2-Encoded Regulator EtrB Modulates Enterohemorrhagic Escherichia coli Virulence Gene Expression.

Authors:  Deborah H Luzader; Graham G Willsey; Matthew J Wargo; Melissa M Kendall
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 9.  Future perspectives, applications and challenges of genomic epidemiology studies for food-borne pathogens: A case study of Enterohemorrhagic Escherichia coli (EHEC) of the O157:H7 serotype.

Authors:  Mark Eppinger; Thomas A Cebula
Journal:  Gut Microbes       Date:  2014-09-01

10.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.